News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • IonQ shifts to wafer-scale Superion manufacturing and reported Q2 revenue up 287% YoY to $80M, signaling revenue growth ahead.
  • Goldman flags seasonal tailwinds for spot truckload rates into year-end, supporting trucking-equity upside.
  • Goldman now expects a 25bp Fed hike on Sept. 16 and no forward guidance from the Fed.
  • BofA raised U.S. semiconductor growth to an 18% CAGR through 2030, lifting wafer-equipment and TAM forecasts.
  • UnitedHealth pulled back from July highs, but 2026 guidance and strong cash flow create a near-term buy opportunity.
  • Nokia jumped pre-market after an analyst upgrade and planned Euro STOXX 50 reentry, likely drawing passive inflows.

Latest Articles

Vistry Shares Slide After Insurer Cuts Supplier Credit Cover

Vistry Shares Slide After Insurer Cuts Supplier Credit Cover

Vistry Group PLC shares dropped 9.0% to 258.09p following reports that Allianz Trade is significantly scaling back credit insurance for the housebuilder's suppliers, with new trading agreement limits potentially reduced by as much as 70%. The insurer's action, highlighted on a distributor earnings call and linked to Vistry by press reports, raises …

European markets trade flat as Hormuz shipping talks keep oil elevated

European markets trade flat as Hormuz shipping talks keep oil elevated

European equities were largely unchanged on Aug 10 as uncertainty over the reopening of the Strait of Hormuz kept crude prices firm. The STOXX 600 held near 660.12 at 0715 GMT after a record close the previous week, while markets prepared for key euro zone employment and U.S. inflation releases amid a fading earnings season.

Vistry Shares Drop After Insurer Reportedly Scales Back Supplier Credit Cover

Vistry Shares Drop After Insurer Reportedly Scales Back Supplier Credit Cover

Vistry’s stock plunged after reports that a major credit insurer is reducing the coverage it provides to the company’s suppliers. The move could cut protection by up to 70% for new trading arrangements, potentially prompting suppliers to demand upfront payments and exerting added pressure on Vistry’s cash flow as the business works to stabilise aft…

Copper Hovers Over $6.58 Support After Rejection Near Record Highs

Copper Hovers Over $6.58 Support After Rejection Near Record Highs

Copper trades at $6.639 on the 5-hour chart and is testing a critical support region at $6.58 after a rejection from recent highs. Short-term technical signals have shifted bearish - including a bearish engulfing candle at $6.8665, weakening MACD and cooling RSI - but significant support from the SuperTrend, Ichimoku cloud and the 50 SMA at $6.53 r…

Bitcoin Locked in Narrow $63.5K-$65.5K Band as Volatility Compresses

Bitcoin Locked in Narrow $63.5K-$65.5K Band as Volatility Compresses

Bitcoin is trading in a tight corridor between $63,500 and $65,500 on the five-hour chart, with volatility compressed and trend indicators weak. Average True Range sits at 0.63% and volume is falling, heightening the probability of false breakouts. Key technical levels include the 200-period simple moving average at $63,733.70 and a SuperTrend read…

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Holding AG has signed an asset purchase agreement with Accure Therapeutics to acquire worldwide rights to the neuroprotective drug candidate Privosegtor and an early-stage preclinical drug ACT-02. This acquisition will terminate the existing license agreement with Accure, eliminating milestone payments and royalties, and allow Oculis to full…

BOE Technology Shares Slide as Rally Unwinds and Market Sentiment Shifts

BOE Technology Shares Slide as Rally Unwinds and Market Sentiment Shifts

BOE Technology Group Co Ltd shares fell 4.1% to 5.82 CNY as investors trimmed positions after a steep rally into early July. The pullback follows heavy deleveraging in margin financing and rising doubt over whether panel-industry earnings gains can be sustained into the third quarter. Market technicians are also signaling a clear sell.

Hypoport Posts Modest Profit Gain in H1 2026, Reaffirms Full-Year Targets

Hypoport Posts Modest Profit Gain in H1 2026, Reaffirms Full-Year Targets

German credit and insurance technology group Hypoport reported a 5% year-on-year increase in gross profit for the first half of 2026 and a 20% rise in EBIT. Second-quarter revenue and gross profit each grew 3% compared with the prior year, with the quarter delivering €66.50 million in gross profit and €7.30 million in EBIT. All three operating segm…

South Korean won Sinks as Dollar Firms; Yen Recedes After Intervention Gains

South Korean won Sinks as Dollar Firms; Yen Recedes After Intervention Gains

The South Korean won was the weakest major Asian currency on Monday as the U.S. dollar strengthened modestly ahead of key U.S. inflation data. The yen retreated after partially surrendering gains from recent coordinated yen-buying intervention, while other regional currencies showed mixed moves amid rising oil prices and upcoming central bank event…

AMD: CapEx-Led Capacity Bump Should Power the Next Up Leg

AMD: CapEx-Led Capacity Bump Should Power the Next Up Leg

AMD looks set to convert aggressive capital spending into a material increase in supply and differentiated product sets that should support revenue and margin expansion over the coming months. This trade idea backs a tactical long with a $140 entry, $175 target and $120 stop on a mid-term (45 trading days) horizon.